Search Results - "Loglisci, G."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    PB2347 NIVOLUMAB AS A BRIDGE TO ALLOGENEIC TRASPLANTATION IN PATIENT WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE OF A SINGLE CENTER by Federico, V., Matera, R., Forese, P., Rossini, B., Loglisci, G., Messa, A., D’Argenio, M., Carlino, D., Luponio, S., Fina, M., Cristofalo, C., Bozzoli, V., Reddiconto, G., De Paolis, M. R., Pugliese, G., Vergine, C., Di Renzo, N.

    Published in HemaSphere (01-06-2019)
    “…Background: Allogeneic hematopoietic stem cell transplantation and checkpoint inhibitors therapy are immune‐based therapies that have activity in selected…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12